BHVN | Biohaven Pharmaceutical Holding Co Ltd Category: Consumer goods Quick infos Headquarters: New Haven, Connecticut, United States Trade prices Volume: Market Cap: 9.32B Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: No Dividends Next ER: November 8, 2021
Biohaven is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
Date EPS / Forecast Revenue / Forecast November 16, 2021 August 9, 2021 -3.23 / -2.76 92.93M / 89.93M Beat! May 10, 2021 -4.21 / -2.85 43.82M / 43.8M Beat! March 1, 2021 -3.62 / -2.9 35.11M / 29.09M Beat! November 9, 2020 -3.27 / -2.84 17.66M / 19.35M view more Historical Data
Date Price Open High Low Vol Change ER Oct 8, 2021 141.68 142.26
266.11K -0.54% Oct 7, 2021 142.45 141.91
369.40K 0.86% Oct 6, 2021 141.24 142.09
296.42K -1.04% Oct 5, 2021 142.72 148.50
893.19K -0.15% Oct 4, 2021 142.93 144.54
424.58K -1.96% Oct 1, 2021 145.78 138.00
591.44K 4.95% Sep 30, 2021 138.91 133.00
629.66K 4.91% Sep 29, 2021 132.41 133.35
240.83K 0.29% Sep 28, 2021 132.03 132.98
323.88K -0.64% Sep 27, 2021 132.88 131.64
648.22K -0.37% view more
NASDAQ - Nasdaq Stock Market
News Biohaven Announces Proposed Public Offering Of Common Shares finance.yahoo.com Aug 10, 2021 4:32 pm Company News for Jul 8, 2021 finance.yahoo.com Aug 10, 2021 9:43 am Biohaven (BHVN) Initiates Pivotal Study on OCD Candidate finance.yahoo.com Aug 10, 2021 9:08 am Biohaven's stock jumps 12% after saying its migraine drug had $93 million in sales in Q2 marketwatch.com Aug 10, 2021 8:44 am Kleo Pharmaceuticals Presents Preclinical Proof-of-Concept Data on a Novel Chemical Conjugation Platform (MATE) at the Society for Immunotherapy of Cancer's (SITC) 35th Annual Meeting finance.yahoo.com Aug 10, 2021 8:00 am Biohaven's Nurtec Wins FDA Approval As First Med to Prevent and Treat Migraine Attacks finance.yahoo.com Aug 10, 2021 8:00 am Recap: Biohaven Pharmaceutical Q4 Earnings finance.yahoo.com Aug 10, 2021 7:59 am Biohaven Pharmaceuticals And Weill Cornell Medicine Collaborate To Initiate Proof Of Concept Trial With CGRP Receptor Antagonist In Plaque Psoriasis finance.yahoo.com Aug 10, 2021 7:30 am Biohaven Enrolls First Patient in Phase 2/3 Trial of Oral Zavegepant, Prompting $100 Million Milestone Funding Payment from Royalty Pharma finance.yahoo.com Aug 10, 2021 7:30 am Biohaven Pharmaceutical Holding Co. Ltd. to Host Earnings Call finance.yahoo.com Aug 10, 2021 6:45 am Biohaven Pharmaceutical Holding Co. Ltd. to Host Earnings Call finance.yahoo.com Aug 10, 2021 6:30 am Biohaven Pharmaceutical Holding Co. Ltd. to Host Earnings Call finance.yahoo.com Aug 10, 2021 6:30 am Biohaven Pharmaceuticals Looks Ready to Trade Higher realmoney.thestreet.com Aug 10, 2021 5:50 am Biohaven Leaps After Posting $93M Sales for Migraine Drug thestreet.com Aug 10, 2021 5:44 am Biohaven (BHVN) Q2 Earnings Miss, Nurtec Uptake Still Strong finance.yahoo.com Aug 9, 2021 12:13 pm News Flash: Analysts Just Made A Sizeable Upgrade To Their Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) Forecasts finance.yahoo.com Jul 23, 2021 1:38 am Why Biohaven Pharmas Prospects Look Healthy barrons.com Jul 16, 2021 7:30 pm New Forecasts: Here's What Analysts Think The Future Holds For Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) finance.yahoo.com Jul 9, 2021 1:31 am Biohaven reports preliminary Q2 NURTEC revenue of $93M; shares rise 12% seekingalpha.com Jul 7, 2021 8:04 pm Biohaven Stock Hits Record High As Migraine Drug Trounces Quarterly Forecasts investors.com Jul 7, 2021 4:09 pm
This company doesn't provide a dividend.
Talk about Biohaven Pharmaceutical Holding Co Ltd below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
If you are looking for News & events, Press Release, they are available on their Investors Relationssite.
If you want to help pay for server cost or for improving this tool. You can send it via
Paypal. More features coming soon :) Buy on Amazon
Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!